Conference Symposia

After the COVID-19 tide: exploring novel approaches in Infectious diseases diagnostics from syndromic to immune testing.

ECCMID 2022 Lisbon, Portugal

The uptake of COVID-19 vaccines has allowed many parts of the world to begin shifting from COVID-19 pandemic to endemic SARS-CoV-2. QIAGEN´s integrated symposium at ECCMID 2022 shares insights from the past 2 years of COVID-19, including themes from COVID-19's impact on respiratory pathogen epidemiology to assessing SARS-CoV-2 adaptive immunity utilising T-cell assays. Experts will review the paradigm shifts in molecular diagnostics from those focused-on influenza like illness (ILI) pathogens to more multiplexed solutions which provide an opportunity to bring together laboratorians and clinicians to improve patient outcomes and gain new perspective into the post pandemic world.

TALK TITLE 1: 2 years into the COVID-19 pandemic: how has infectious diseases diagnostic testing evolved
SPEAKER: Dr Benoit Visseaux
TALK START TIME: minute 2

TALK TITLE 2: Syndromic testing in the age of COVID-19
SPEAKER: Dr Melissa Miller
TALK START TIME: minute 22

TALK TITLE 3: Vaccine-induced immunity to COVID-19: role of T-cell responses
SPEAKER: Dr Martina Sester
TALK START TIME: minute 52

TALK TITLE 4: Clinical utility of cycle threshold (Ct) values: lessons learned from COVID-19 and application in the future
SPEAKER: Dr Nathan Ledeboer T
ALK START TIME: minute 75

Panel discussion – Q&A: minute 105

Our team is here to help

Get in touch with our medical affairs team

Contact us